Lataa...
Tumor and Endothelial Cell Hybrids Participate in Glioblastoma Vasculature
Background. Recently antiangiogenic therapy with bevacizumab has shown a high but transient efficacy in glioblastoma (GBM). Indeed, GBM is one of the most angiogenic human tumors and endothelial proliferation is a hallmark of the disease. We therefore hypothesized that tumor cells may participate in...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi Limited
2014-01-01
|
| Sarja: | BioMed Research International |
| Linkit: | http://dx.doi.org/10.1155/2014/827327 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|